# CHARLIE NORWOOD VA MEDICAL CENTER: Targeting spermine oxidase to prevent vision loss in Multiple Sclerosis

**Lab Budget Score:** 15/100

| Field | Value |
|---|---|
| Organization | CHARLIE NORWOOD VA MEDICAL CENTER |
| Location | AUGUSTA, GA |
| Project | Targeting spermine oxidase to prevent vision loss in Multiple Sclerosis |
| Project number | 5I01BX005193-05 |
| Mechanism | I01 |
| Institute | Veterans Affairs |
| Awarded | 2026-09-18 |
| Project period | 2021-10-01 to 2026-09-30 |
| UEI | G9ALQLHWSG28 |

## Why this score


Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11457774). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.